HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 6, 2006, Pages 759-767

  Rey Cuillé, Marie Anne ^a   Svab, Josette ^a   Benferhat, Rima ^a   Krust, Bernard ^a   Briand, Jean Paul ^b   Muller, Sylviane ^b   Hovanessian, Ara G ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CAVEOLIN 1; CBD1 ANTIBODY; EPITOPE; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; PROLINE; TRYPTOPYLASPARAGYLASPARAGYLMETHIONYLTHREONYLTRYPTOPHYLMETHIONYLGLUTAMYLTRYTOPHAN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN;

AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CAVEOLIN 1; CROSS REACTIONS; EPITOPE MAPPING; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV-1; IMMUNE SERA; MOLECULAR SEQUENCE DATA; RABBITS;

EID: 33744918518     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.6.0006     Document Type: Article

References (41)

1. Alfsen, A., Iniguez, P., Bouguyon, E., Bomsel, M. (2001) Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J. Immunol. 166: 6257-6265
2. Brown, D. A., London, E. (2000) Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275: 17221-17224
3. Campbell, S. M., Crowe, S. M., Mak, J. (2001) Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J. Clin. Virol. 22: 217-227
4. Cao, C., Bai, Y., Holloway, M. J., Edgeworth, R. L., Jackson, E. A. J., Cotropia, J. P., Ugen, K. E. (2004) Characterization of a novel human anti-HIV-1 gp41 IgM monoclonal antibody designated clone 37. DNA Cell Biol. 23: 836-841
5. Cardoso, R. M., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., Wilson, I. A. (2005) Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 22: 163-173
6. Chan, D. C., Chutkowski, C. T., Kim, P. S. (1998) Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc. Natl Acad. Sci. USA 95: 15613-15617
7. Chen, X., Rock, M. T., Hammonds, J., Tartaglia, J., Shintani, A., Currier, J., Slike, B., Crowe, J. E. J., Marovich, M., Spearman, P. (2005) Pseudovirion particles by live poxvirus human immunodeficiency virus vector enhances humoral and cellular immune response. J. Virol. 79: 5537-5547
8. Couet, J., Li, S., Okamoto, T., Ikezu, T., Lisanti, M. P. (1997) Identification of peptide and protein ligands for the caveolin-scaffolding domain. J. Biol. Chem. 272: 6525-6533
9. Dong, X. N., Yi, X., Dierich, M. P., Chen, B. K. (2001) N- and C-domains of HIV-1 gp41: mutation, structure and functions. Immunol. Lett. 75: 215-220
10. Eckert, D. M., Kim, P. S. (2001) Mechanism of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70: 777-810
11. Halwani, R., Khorchid, A., Cen, S., Kleiman, L. (2003) Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1. J. Virol. 77: 3973-3984
12. Harder, T., Scheiffele, P., Verkade, P., Simons, K. (1998) Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141: 929-942
13. Hovanessian, A. G., Puvion-Dutilleul, F., Nisole, S., Svab, J., Perret, E., Deng, J. S., Krust, B. (2000) The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp. Cell Res. 261: 312-328
14. Hovanessian, A. G., Briand, J. P., Said, A. S., Svab, J., Ferris, S., Dali, H., Muller, S., Desgranges, C., Krust, B. (2004) The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B-cell epitope vaccine candidate against virus infection. Immunity 21: 617-720
15. Jacobs, A., Sen, J., Rong, L., Caffrey, M. (2005) Alanine scanning mutants of the HIV gp41 loop. J. Biol. Chem. 280: 27284-27288
16. Johnson, W. E., Sauvron, J. M., Desrosiers, R. C. (2001) Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication. J. Virol. 15: 11426-11436
17. Kadsumoto, T., Asanaka, M., Kageyama, S., Kurimura, T., Nakajima, K., N., A., Tanaka, H., Sato, R. (1990) Budding process and maturation of human immunodeficiency virus examined by means of pre- and post-embedding immunocolloidal gold electron microscopy. J. Electron Microsc. 39: 33-38
18. Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., Mathews, T., Johnson, M. R., Nowak, M. A., Shaw, G. M., Saag, M. S. (1998) Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4: 1302-1307
19. Kuiken, C., Foley, B., Hahn, B., Marx, P., McCurchan, F., Mellors, J., Mullins, J., Sodroski, J. G., Wolinsky, S., Korber, B. (2000) HIV sequence compendium 2000. Theoretical Biology and Biophysics Group T-10, Los Alamos National Laboratory, Los Alamos, New Mexico.
20. Laurent-Crawford, A. G., Krust, B., Rivière, Y., Desgranges, C., Muller, S., Kieny, M. P., Dauguet, C., Hovanessian, A. G. (1993) Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res. Hum. Retroviruses 9: 761-773
21. Leitgeb, B., Toth, G. (2005) Aromatic-aromatic and proline-aromatic interactions in endomorphin-1 and endomorphin-2. Eur. J. Med. Chem. 40: 674-686
22. Liao, Z., Cimakasky, L. M., Hampton, R., Nguyen, D. H., Hildreth, J. E. K. (2001) Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retroviruses 17: 1009-1019
23. Liu, P., Rudick, M., Anderson, R. G. W. (2002) Multiple functions of caveolin-1. J. Biol. Chem. 277: 41295-41298
24. Manes, S., Del Real, G., Lacalle, R. A., Lucas, P., Gomez-Mouton, C., Sanchez-Palomino, S., Delgado, R., Alcami, J., Mira, E., Martinez-A, C. (2000) Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Reports 1: 190-196
25. McMichael, A. J., Hanke, T. (2003) HIV vaccines 1983-2003. Nat. Med. 9: 874-880
26. Moore, J. P., Parren, P. W. H. I., Burton, D. R. (2001) Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. J. Virol. 75: 5721-5729
27. Neimark, J., Briand, J. P. (1993) Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. Peptide Res. 6: 219-228
28. Nguyen, D. H., Hildreth, J. E. K. (2000) Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid enriched membrane lipid rafts. J. Virol. 74: 3264-3272
29. Nisole, S., Krust, B., Hovanessian, A. G. (2002) Anchorage of HIV on permissive cells leads to co-aggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp. Cell Res. 276: 155-173
30. Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., Kwong, P. D. (2004) Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J. Virol. 78: 10724-10737
31. Okamoto, T., Schlegel, A., Scherer, P. E., Lisanti, M. P. (1998) Caveolins, a family of scaffolding proteins for organizing 'pre-assembled signaling complexes' at the plasma membrane. J. Biol. Chem. 273: 5419-5422
32. Ono, A., Freed, E. O. (2001) Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl Acad. Sci. USA 98. 13925-13930
33. Parren, P. W., Burton, D. R. (2001) The antiviral activity of antibodies in vitro and in vivo. Adv. Immunol. 77: 195-262
34. Phan Chan Du, A., Limal, D., Semetey, V., Dali, H., Jolivet, M., Desgranges, C., Cung, M. T., Briand, J. P., Petit, M. C., Muller, S. (2002) Structural and immunological characterisation of heteroclitic peptide analogues corresponding to the 600-612 region of the HIV envelope gp41 glycoprotein. J. Mol. Biol. 323: 503-521
35. Rey-Cuillé, M. A., Galabru, J., Laurent-Crawford, A. G., Krust, B., Montagnier, L., Hovanessian, A. G. (1994) HIV-2 EHO isolate has a divergent envelope gene and induces single cell killing by apoptosis. Virology 202: 471-476
36. Saez-Cirion, A., Nir, S., Lorizate, M., Agirre, A., Cruz, A., Ferez, J., Nieva, J. L. (2002) Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation at membrane restructuring. J. Biol. Chem. 277: 21776-21785
37. Salzwedel, K., West, J. T., Hunter, E. (1999) A conserved tryptophane-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J. Virol. 73: 2469-2480
38. Smart, E. J., Graf, G. A., McNiven, M. A., Sessa, W. C., Engelman, J. A., Scherer, P. E., Okamoto, T., Lisanti, M. P. (1999) Caveolins, liquid-ordered domains and signal transduction. Mol. Cell Biol. 19: 7289-7304
39. Suarez, T., Gallaher, W. R., Agirre, A., Goni, F. M., Nieva, J. L. (2000) Membrane-interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion. J. Biol. Chem. 74: 8038-8047
40. Vincent, N., Genin, C., Malvoisin, E. (2002) Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups. Biochim. Biophys. Acta 1567: 157-164
41. Weng, Y., Yang, Z., Weiss, C. (2000) Structure-function studies of the self-assembly domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 74: 5368-5372